Charity Michal Anderson LPC-I

Recommended Articles

• What is Lyme Disease? A General Overview of the Disease

  Lyme disease is a tick-borne infectious disease. It is caused by a spiral shaped bacterium known as borrelia burgdorferi sensu lato. A common tick is the carrier of this bacterium.The first incidence of lyme disease was reported in 1975 in a town called Old Lyme in Connecticut. Lyme disease is the...

• Black Cohosh: Uses, Benefits, and Side Effects

  What is black cohosh?Black cohosh is an herbal flowering plant, which is mostly grown in various parts of Canada and the United States. It comes from the family of buttercup. The roots of this plant are dark colored, hence the name “black cohosh”. These roots are used for various medicinal...

• Is the Keratin Hair Treatment Safe?

  Keratin hair treatment, or Brazilian treatment, seems to be the ideal method for most women. It smoothens out the frizz and curls from the hair and gives it a uniform texture. But this treatment is a temporary curl softening method. Normal hair straightening methods use harsh chemicals to make hair...

• Investigating Lumps in Your Breasts

  If you have felt a new breast lump that is the same or increasing in size gradually, it is always wise to show this to your health care professional. They will then do a series of tests to investigate if you have a benign lump or breast cancer. Diagnosing and treating early will give you a better...

• Sleep Apnea Machines: What's a CPAP?

  Sleep Apnea, a sleeping disorder that causes breathing interruption during sleep, has some serious effects if left untreated. The most common and effective treatment for sleep apnea is the CPAP or Continuous Positive Airway Pressure Therapy which aids patients in breathing when asleep.How does CPAP...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...